6N4I image
Deposition Date 2018-11-19
Release Date 2019-01-23
Last Version Date 2024-11-20
Entry Detail
PDB ID:
6N4I
Keywords:
Title:
Structural basis of Nav1.7 inhibition by a gating-modifier spider toxin
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.54 Å
R-Value Free:
0.29
R-Value Work:
0.27
R-Value Observed:
0.27
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Nav1.7 VSD2-NavAb channel chimera protein
Chain IDs:A, B, C, D
Chain Length:288
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Beta/omega-theraphotoxin-Tp2a
Chain IDs:E, F, G, H
Chain Length:30
Number of Molecules:4
Biological Source:Thrixopelma pruriens
Ligand Molecules
Primary Citation
Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider Toxin.
Cell 176 702 715.e14 (2019)
PMID: 30661758 DOI: 10.1016/j.cell.2018.12.018

Abstact

Voltage-gated sodium (Nav) channels are targets of disease mutations, toxins, and therapeutic drugs. Despite recent advances, the structural basis of voltage sensing, electromechanical coupling, and toxin modulation remains ill-defined. Protoxin-II (ProTx2) from the Peruvian green velvet tarantula is an inhibitor cystine-knot peptide and selective antagonist of the human Nav1.7 channel. Here, we visualize ProTx2 in complex with voltage-sensor domain II (VSD2) from Nav1.7 using X-ray crystallography and cryoelectron microscopy. Membrane partitioning orients ProTx2 for unfettered access to VSD2, where ProTx2 interrogates distinct features of the Nav1.7 receptor site. ProTx2 positions two basic residues into the extracellular vestibule to antagonize S4 gating-charge movement through an electrostatic mechanism. ProTx2 has trapped activated and deactivated states of VSD2, revealing a remarkable ∼10 Å translation of the S4 helix, providing a structural framework for activation gating in voltage-gated ion channels. Finally, our results deliver key templates to design selective Nav channel antagonists.

Legend

Protein

Chemical

Disease

Primary Citation of related structures